These 3 Indian pharma firms to benefit from warning letter to Mylan#39;s US facility

These 3 Indian pharma firms to benefit from warning letter to Mylan#39;s US facility The slowdown in production at Morgantown site could provide a window of opportunity to Mylan#39;s peers

No comments:

Post a Comment